title: Why lithium studies for ALS treatment should not be halted prematurely.
authors.affiliation: Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences and Psychiatry Research Unit, Ben Gurion University of the Negev Beer Sheva, Israel.
authors.forename: Galila
authors.initials: G
authors.lastname: Agam
authors.affiliation: Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben Gurion University of the Negev Beer Sheva, Israel.
authors.forename: Adrian
authors.initials: A
authors.lastname: Israelson
keywords: ALS; effective blood levels; lithium; mouse strains; riluzole